Annual Hospitalizations for COVID-19, Influenza, and Respiratory Syncytial Virus, United States, 2023–2024
Kaiming Bi, Shraddha Ramdas Bandekar, Anass Bouchnita, Spencer J. Fox, Lauren Ancel Meyers
Abstract
Projections for the US 2023-24 respiratory virus season indicated a 31% decrease to a 55% increase in hospitalizations for respiratory syncytial virus, influenza, and COVID-19 compared with 2022-23, depending on circulating variants and vaccination uptake. The projections captured the tripledemic peak but missed the multiwave seasonality of COVID-19.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)VirologyRespiratory systemMedicine2019-20 coronavirus outbreakVirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Influenza A virusEnvironmental healthInternal medicineOutbreakInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchRespiratory viral infections researchCOVID-19 Clinical Research Studies